Sevoflurane and Propofol for Botulinum Toxin Injection

• Status: Not yet recruiting
• Trial end date: 2026-02-28
• Target enrollment: 0
• Participant gender: All

Summary

The investigators would like to compare clinical features (onset, duration, emergence time), efficacy of deep sedation (successful completion of procedure), safety (adverse events) and caregiver's satisfaction for sedation when used propofol and sevoluflurane for deep sedation in 3-11 year old pediatric patients with spastic cerebral palsy receiving botulinum toxin injection.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yeungnam University College of Medicine
• Treatments: Propofol; Sevoflurane

Criteria

Inclusion Criteria:

• Children with cerebral palsy (ages 3-11)

Exclusion Criteria:

① Obestity : Body Mass Index of 30 kg/m2 or more

• Heart disease : NYHA class >2

• Laryngomalacia

• Acute upper respiratory disease or asthma ⑤ Gastroesophageal reflux disease ⑥ Allergy to general anesthetics and drugs planned for use in this study